Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-28
DOI
10.3389/fpsyt.2020.00315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior
- (2019) Chen-Jie Shen et al. NATURE MEDICINE
- Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
- (2019) Thércia G. Viana et al. NEUROPHARMACOLOGY
- Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats
- (2019) Alice Hartmann et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder
- (2019) Douglas T. Leffa et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment
- (2019) Mohaddeseh Ebrahimi-Ghiri et al. BEHAVIOURAL BRAIN RESEARCH
- Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
- (2019) Fatemeh Khakpai et al. BIOMEDICINE & PHARMACOTHERAPY
- Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
- (2019) Jacob D. Meyer et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression
- (2019) C. Kirkedal et al. NEUROCHEMISTRY INTERNATIONAL
- Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
- (2019) Pablo Romero-Sanchiz et al. NEUROPHARMACOLOGY
- Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
- (2019) Xenia Gonda et al. Frontiers in Cellular Neuroscience
- Bipolar disorder and the endocannabinoid system
- (2019) Shokouh Arjmand et al. ACTA NEUROPSYCHIATRICA
- Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: Current approaches for therapeutics development
- (2019) Thuy Nguyen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
- (2019) Carolina Muguruza et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
- (2019) Luara A. Batista et al. NEUROSCIENCE LETTERS
- Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling
- (2019) Shan-shan Xue et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
- (2019) Faith Borgan et al. JAMA Psychiatry
- NMDAR Hypofunction Animal Models of Schizophrenia
- (2019) Gloria Lee et al. Frontiers in Molecular Neuroscience
- Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis
- (2019) Martina Rojnic Kuzman et al. EUROPEAN PSYCHIATRY
- Impaired brain endocannabinoid tone in the activity‐based model of anorexia nervosa
- (2019) Roberto Collu et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
- (2019) Valéria Almeida et al. NEUROPHARMACOLOGY
- Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits
- (2019) Sophie E. Legge et al. JAMA Psychiatry
- A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
- (2019) Judit Lazary et al. JOURNAL OF AFFECTIVE DISORDERS
- Phenolic compounds from nutmeg ( Myristica fragrans Houtt.) inhibit the endocannabinoid‐modulating enzyme fatty acid amide hydrolase
- (2019) Abir T. El‐Alfy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression
- (2019) Xiangjuan Kong et al. MEDICINE
- Schizophrenia
- (2019) Stephen R. Marder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour
- (2019) Elizabeth A. Hay et al. PSYCHONEUROENDOCRINOLOGY
- Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
- (2019) Eun-Sang Hwang et al. BEHAVIOURAL BRAIN RESEARCH
- Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats
- (2019) Bin Dong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD
- (2019) Neta Maymon et al. NEUROPHARMACOLOGY
- The endocannabinoid system in mental disorders: Evidence from human brain studies
- (2018) Inés Ibarra-Lecue et al. BIOCHEMICAL PHARMACOLOGY
- The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System
- (2018) Anthony L. Berger et al. BIOLOGICAL PSYCHIATRY
- Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
- (2018) Sharon Fidelman et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
- (2018) Aitziber Mendiguren et al. LIFE SCIENCES
- Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats
- (2018) Guoxiang Fang et al. NEUROCHEMICAL RESEARCH
- Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats
- (2018) Giorgia Boero et al. NEUROPHARMACOLOGY
- Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity
- (2018) Amir Segev et al. NEUROPSYCHOPHARMACOLOGY
- Sex differences in psychiatric disorders: what we can learn from sex chromosome aneuploidies
- (2018) Tamar Green et al. NEUROPSYCHOPHARMACOLOGY
- Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2
- (2018) Sabrina Francesca Lisboa et al. NEUROPSYCHOPHARMACOLOGY
- Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
- (2018) María S. García-Gutiérrez et al. Neurotherapeutics
- Familial abnormalities of endocannabinoid signaling in schizophrenia
- (2018) Dagmar Koethe et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
- (2018) Gaurav Bedse et al. Translational Psychiatry
- Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats
- (2018) Jonathan J. Simone et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety
- (2018) Andalib Danandeh et al. PSYCHOPHARMACOLOGY
- Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
- (2018) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
- (2018) Guy Griebel et al. Scientific Reports
- Impact of FAAH genetic variation on fronto-amygdala function during emotional processing
- (2018) Anne Gärtner et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety
- (2018) Maria Morena et al. JOURNAL OF NEUROSCIENCE
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
- (2018) Tina Zimmermann et al. NEUROPSYCHOPHARMACOLOGY
- Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat
- (2018) Stephanie M. Perez et al. SCHIZOPHRENIA RESEARCH
- Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
- (2017) Laura Kranaster et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event
- (2017) Nurit Aisenberg et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia
- (2017) Jennifer L. Neary et al. GENOMICS
- Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
- (2017) Salvina Maria de Campos-Carli et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents
- (2017) Tingting Duan et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex
- (2017) Ana F Almeida-Santos et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event
- (2017) Noa Shoshan et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The CB1 Receptor as the Cornerstone of Exostasis
- (2017) Pier Vincenzo Piazza et al. NEURON
- Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex
- (2017) Ermelinda Lomazzo et al. NEUROPHARMACOLOGY
- CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
- (2017) Arnau Busquets-Garcia et al. NEUROPSYCHOPHARMACOLOGY
- Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
- (2017) Ziva D Cooper et al. NEUROPSYCHOPHARMACOLOGY
- Anxious behavior induces elevated hippocampal Cb 2 receptor gene expression
- (2017) James M. Robertson et al. NEUROSCIENCE
- Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders
- (2017) Nachshon Korem et al. NEUROSCIENCE
- Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus
- (2017) Yong Li et al. NEUROSCIENCE
- The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
- (2017) Marta Kruk-Slomka et al. NEUROTOXICITY RESEARCH
- Changes in the cannabinoids receptors in rats following treatment with antidepressants
- (2017) Irena Smaga et al. NEUROTOXICOLOGY
- A behavioral and pharmacological characterization of palatable diet alternation in mice
- (2017) Catherine F. Moore et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
- (2017) Andrea Chicca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia
- (2017) David J. Clarke et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
- (2017) Sagnik Bhattacharyya et al. Scientific Reports
- Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression
- (2017) Hoyong Park et al. Cell Reports
- Schizophrenia and depression, two poles of endocannabinoid system deregulation
- (2017) María Rodríguez-Muñoz et al. Translational Psychiatry
- Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
- (2017) Qing-Rong Liu et al. Scientific Reports
- Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
- (2016) Mallory E. Bowers et al. BEHAVIOURAL BRAIN RESEARCH
- Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
- (2016) Mohini Ranganathan et al. BIOLOGICAL PSYCHIATRY
- Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions
- (2016) Catherine H. Demers et al. BIOLOGICAL PSYCHIATRY
- Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
- (2016) Yoan Mihov BIOLOGICAL PSYCHIATRY
- Human Laboratory Studies on Cannabinoids and Psychosis
- (2016) Mohamed Sherif et al. BIOLOGICAL PSYCHIATRY
- Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
- (2016) Imke Jenniches et al. BIOLOGICAL PSYCHIATRY
- Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
- (2016) Shanshan Wang et al. BRAIN RESEARCH BULLETIN
- Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1receptor inverse agonist AM-251 after physical stress in mice
- (2016) Sattar Ostadhadi et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
- (2016) P.H. Gobira et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
- (2016) Judit Lazary et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Targeting the Endocannabinoid System in Psychiatric Illness
- (2016) Martin A. Katzman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Anatomical characterization of the cannabinoid CB1receptor in cell-type-specific mutant mouse rescue models
- (2016) Ana Gutiérrez-Rodríguez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats
- (2016) Dhanush Haspula et al. JOURNAL OF NEUROCHEMISTRY
- Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala
- (2016) S. Di et al. JOURNAL OF NEUROSCIENCE
- Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
- (2016) Miquel Bioque et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
- (2016) Maria Morena et al. NEUROPHARMACOLOGY
- Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
- (2016) Edina Szűcs et al. NEUROSCIENCE LETTERS
- The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
- (2016) Marta Kruk-Slomka et al. NEUROTOXICITY RESEARCH
- The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings
- (2016) Andrea Berardi et al. PHARMACOLOGICAL RESEARCH
- Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor
- (2016) Tamaki Hayase PLoS One
- Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
- (2016) Dylan G. Gee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
- (2016) Kayla A. Chase et al. PSYCHIATRY RESEARCH
- Endocannabinoid concentrations in hair are associated with PTSD symptom severity
- (2016) Sarah Wilker et al. PSYCHONEUROENDOCRINOLOGY
- Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
- (2016) J. Megan Gray et al. PSYCHONEUROENDOCRINOLOGY
- Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
- (2016) Clémentine Bosch-Bouju et al. Cell Reports
- The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors
- (2015) Priscila A. Batista et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
- (2015) Marta Kruk-Slomka et al. BEHAVIOURAL BRAIN RESEARCH
- Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression
- (2015) Ricardo Lage et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
- (2015) Stephan Guggenhuber et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
- (2015) Elizabeth Scarr et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The rs1049353 Polymorphism in the CNR1 Gene Interacts With Childhood Abuse to Predict Posttraumatic Threat Symptoms
- (2015) Natalie Mota et al. JOURNAL OF CLINICAL PSYCHIATRY
- Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior
- (2015) Roberta Imperatore et al. JOURNAL OF NEUROCHEMISTRY
- Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
- (2015) J. M. Gray et al. JOURNAL OF NEUROSCIENCE
- Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses
- (2015) Luara A Batista et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia
- (2015) Stephanie M Perez et al. NEUROPSYCHOPHARMACOLOGY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
- (2015) Eva M. Marco et al. PLoS One
- Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
- (2015) Sabrina F. Lisboa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
- (2015) Paula Suárez-Pinilla et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
- (2015) Rakesh Jetly et al. PSYCHONEUROENDOCRINOLOGY
- FAAH genetic variation enhances fronto-amygdala function in mouse and human
- (2015) Iva Dincheva et al. Nature Communications
- Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability
- (2015) Martin Häring et al. Frontiers in Behavioral Neuroscience
- Psychiatric Disorders: Diagnosis to Therapy
- (2014) John H. Krystal et al. CELL
- Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
- (2014) Pablo Roitman et al. CLINICAL DRUG INVESTIGATION
- Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity
- (2014) Zhen Zhang et al. HIPPOCAMPUS
- Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications
- (2014) Colin Cameron et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents
- (2014) Arlette F. Buchmann et al. JOURNAL OF NEURAL TRANSMISSION
- Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
- (2014) Aurelijus Burokas et al. JOURNAL OF NEUROCHEMISTRY
- Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system
- (2014) Hua-ning Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Endocannabinoids, Related Compounds and Their Metabolic Routes
- (2014) Filomena Fezza et al. MOLECULES
- Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
- (2014) Nachshon Korem et al. NEUROPSYCHOPHARMACOLOGY
- Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention
- (2014) Mallory E Bowers et al. NEUROPSYCHOPHARMACOLOGY
- Dissociable Deficits of Executive Function Caused by Gestational Adversity are Linked to Specific Transcriptional Changes in the Prefrontal Cortex
- (2014) Nicola M Grissom et al. NEUROPSYCHOPHARMACOLOGY
- Peripheral and intra-dorsolateral striatum injections of the cannabinoid receptor agonist WIN 55,212-2 impair consolidation of stimulus–response memory
- (2014) J. Goodman et al. NEUROSCIENCE
- Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
- (2014) Irena Smaga et al. NEUROTOXICITY RESEARCH
- The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze
- (2014) Larissa Kochenborger et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population
- (2014) Joon Seol Bae et al. PSYCHIATRIC GENETICS
- CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice
- (2014) Ramy Khella et al. PSYCHOPHARMACOLOGY
- Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats
- (2014) Thércia G. Viana et al. PSYCHOPHARMACOLOGY
- Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia
- (2014) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
- (2014) Rodrigo Ferretjans et al. SCHIZOPHRENIA RESEARCH
- Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
- (2014) Brian C. Shonesy et al. Cell Reports
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
- (2014) R J Bluett et al. Translational Psychiatry
- Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
- (2013) A.F. Almeida-Santos et al. BEHAVIOURAL BRAIN RESEARCH
- CB1receptor signaling regulates social anxiety and memory
- (2013) Y. Litvin et al. GENES BRAIN AND BEHAVIOR
- Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice
- (2013) Mano Aliczki et al. HORMONES AND BEHAVIOR
- Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
- (2013) Mateus M. Bergamaschi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
- (2013) Weiping Yu et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population
- (2013) Dongxiao Tong et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats
- (2013) Christian G Reich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans
- (2013) Christine A. Rabinak et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
- (2013) Jenny Ceccarini et al. NEUROIMAGE
- Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression
- (2013) Amir Segev et al. NEUROPSYCHOPHARMACOLOGY
- Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
- (2013) Miquel Bioque et al. NEUROPSYCHOPHARMACOLOGY
- No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample
- (2013) Claudia Pisanu et al. PSYCHIATRY RESEARCH
- Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
- (2013) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
- (2013) Eti Ganon-Elazar et al. PSYCHONEUROENDOCRINOLOGY
- Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus
- (2013) Rodrigo Rorato et al. REGULATORY PEPTIDES
- Endocannabinoid metabolism in the prefrontal cortex in schizophrenia
- (2013) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models
- (2013) Tim Karl Frontiers in Behavioral Neuroscience
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
- (2012) Arpana Agrawal et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test
- (2012) Priscila Cagni et al. BEHAVIOURAL BRAIN RESEARCH
- The Endocannabinoid System and Pain
- (2012) Josee Guindon et al. CNS & Neurological Disorders-Drug Targets
- Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia
- (2012) Marta Costa et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
- (2012) Kwang Choi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
- (2012) Marina Mitjans et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure
- (2012) M N Hill et al. MOLECULAR PSYCHIATRY
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
- Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
- (2012) J. Kleijn et al. NEUROCHEMISTRY INTERNATIONAL
- The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior
- (2012) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Cannabinoid facilitation of fear extinction memory recall in humans
- (2012) Christine A. Rabinak et al. NEUROPHARMACOLOGY
- Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
- (2012) Alejandro Aparisi Rey et al. NEUROPSYCHOPHARMACOLOGY
- Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms
- (2012) Alline Cristina Campos et al. NEUROSCIENCE LETTERS
- Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
- (2012) Maha M. ElBatsh et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats
- (2012) K. Yaragudri Vinod et al. PLoS One
- The CNR1 gene in depression and schizophrenia — Is there an association with early improvement and response?
- (2012) Rebecca Schennach et al. PSYCHIATRY RESEARCH
- Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
- (2012) Marc Schroeder et al. PSYCHONEUROENDOCRINOLOGY
- Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia
- (2012) Kimberly J. Jenko et al. SCHIZOPHRENIA RESEARCH
- Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
- (2012) Joëlle Desfossés et al. Frontiers in Psychiatry
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
- (2011) Sudhir N. Umathe et al. BEHAVIOURAL BRAIN RESEARCH
- Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
- (2011) Nathalie Gérard et al. BIOLOGICAL PSYCHIATRY
- Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses
- (2011) Arnau Busquets-Garcia et al. BIOLOGICAL PSYCHIATRY
- Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor
- (2011) D. Minocci et al. JOURNAL OF AFFECTIVE DISORDERS
- The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
- (2011) Francisco Javier Bermudez-Silva et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense Stress
- (2011) Eti Ganon-Elazar et al. NEUROPSYCHOPHARMACOLOGY
- CB1 receptor-deficient mice as a model for depression
- (2011) O. Valverde et al. NEUROSCIENCE
- Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
- (2011) Guoqiang Xing et al. NEUROSCIENCE LETTERS
- Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review
- (2011) R. J. Van Lieshout et al. Obesity Reviews
- Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
- (2011) Natale R. Sciolino et al. PHARMACOLOGICAL RESEARCH
- Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression
- (2011) E. Heyman et al. PSYCHONEUROENDOCRINOLOGY
- Energy balance regulation by endocannabinoids at central and peripheral levels
- (2011) Carmelo Quarta et al. TRENDS IN MOLECULAR MEDICINE
- Supply and demand for endocannabinoids
- (2011) Bradley E. Alger et al. TRENDS IN NEUROSCIENCES
- Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
- (2011) Tiziana Rubino et al. Frontiers in Behavioral Neuroscience
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
- (2011) Eva Marco Frontiers in Behavioral Neuroscience
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype
- (2010) Ester Aso et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system and psychiatric disorders
- (2010) Daniela Parolaro et al. EXPERIMENTAL NEUROLOGY
- Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine
- (2010) Cinzia Guidali et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
- (2010) Y. Gao et al. JOURNAL OF NEUROSCIENCE
- Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice
- (2010) Leyre Urigüen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
- (2010) Mohammad Reza Zarrindast et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
- (2010) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition
- (2010) S. Rossi et al. MOLECULAR PHARMACOLOGY
- Depression-like phenotype following chronic CB1 receptor antagonism
- (2010) Chad E. Beyer et al. NEUROBIOLOGY OF DISEASE
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
- (2010) Asami Tanimura et al. NEURON
- Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats
- (2010) N. Realini et al. NEUROPHARMACOLOGY
- Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress
- (2010) Wei Wang et al. NEUROPSYCHOPHARMACOLOGY
- Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience
- (2010) A.C. Campos et al. NEUROSCIENCE
- Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
- (2010) Palmiero Monteleone et al. PHARMACOLOGICAL RESEARCH
- A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
- (2010) Sarah A. Eisenstein et al. PHARMACOLOGICAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
- (2010) Steven G. Kinsey et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
- (2010) Mark D. Black et al. PSYCHOPHARMACOLOGY
- Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype
- (2009) Judit Lazary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
- (2009) Emmanuel S. Onaivi et al. Annals of the New York Academy of Sciences
- Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
- (2009) Gunnar Thiemann et al. BEHAVIOURAL BRAIN RESEARCH
- Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats
- (2009) Christian G. Reich et al. BEHAVIOURAL BRAIN RESEARCH
- Prepulse inhibition and genetic mouse models of schizophrenia
- (2009) Susan B. Powell et al. BEHAVIOURAL BRAIN RESEARCH
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
- (2009) Gernot Riedel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Involvement of hypothalamic peptides in the anorectic action of the CB1receptor antagonist rimonabant (SR 141716)
- (2009) Aaron N. A. Verty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
- (2009) Guy A. Cabral et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cannabinoids modulate hippocampal memory and plasticity
- (2009) Hila Abush et al. HIPPOCAMPUS
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Altered CB1receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
- (2009) Antonio Rodríguez-Gaztelumendi et al. JOURNAL OF NEUROCHEMISTRY
- The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
- (2009) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833
- (2009) Bing Hu et al. PAIN
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- (2009) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats
- (2009) J. Haller et al. PSYCHOPHARMACOLOGY
- Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder
- (2008) Ake T. Lu et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system
- (2008) Mohammad-Reza Zarrindast et al. BEHAVIOURAL PHARMACOLOGY
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to Schizophrenia
- (2008) Mihály Hajós et al. BIOLOGICAL PSYCHIATRY
- Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
- (2008) Ahmad R. Hariri et al. BIOLOGICAL PSYCHIATRY
- Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test
- (2008) Sabrina F. Lisboa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
- (2008) Daniela Vigano et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
- (2008) Matthew N. Hill et al. JOURNAL OF NEURAL TRANSMISSION
- BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1knockout mice
- (2008) Ester Aso et al. JOURNAL OF NEUROCHEMISTRY
- Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
- (2008) Matthew N. Hill et al. JOURNAL OF NEUROCHEMISTRY
- Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
- (2008) Stéphane Potvin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
- (2008) Vincenzo Micale et al. NEUROPSYCHOPHARMACOLOGY
- Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
- (2008) M. Hill et al. PHARMACOPSYCHIATRY
- Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
- (2008) Emmanuel S. Onaivi et al. PLoS One
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
- (2007) Nora Hamdani et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
- (2007) T. Rubino et al. NEUROPHARMACOLOGY
- The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
- (2007) Maria Scherma et al. NEUROPHARMACOLOGY
- Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
- (2007) Fabricio A. Moreira et al. NEUROPHARMACOLOGY
- Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice
- (2007) Nima Naderi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now